The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT03142152
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Cardiac Dimensions, Inc.
- Registry
-
NCT03142152
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, France, Greece, Italy, Poland, Spain, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT03142152. Randomized; double masking; primary purpose treatment. Start 2018-01-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Condition
- Functional Mitral Regurgitation
- Condition
- Heart Failure
- Condition
- Mitral Valve Insufficiency
- Condition
- Heart Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Heart Valve Diseases
- Intervention (Device)
- Carillon Mitral Contour System
- Intervention (Other)
- Guideline Directed Heart Failure Medication
- Lead sponsor
- Cardiac Dimensions, Inc.
Record details
- Record id
cardio:ct-nct03142152- Content hash
8bcf4d3df89ee19f1188202211aa393e56806e32f16c393775d02b7651c771ad